PRA Health Sciences Inc (NASDAQ:PRAH)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - PRAH

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - PRAH

  • Market Cap$10.853bn
  • IndustryHealthcare
  • SectorDiagnostics & Research
  • Currency
  • ISINUS69354M1080

Company Profile

PRA Health Sciences is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology firms. Its services run from early- to late-stage clinical trial outsourcing with varying levels of support, including one-off specialized staffing services to strategic partnerships where PRA handles nearly all aspects of the trial. In 2017, PRA acquired Symphony Health, a healthcare data and analytics provider. PRA's competitor, Icon, announced it will acquire PRA for $12 billion, which is scheduled to close in third-quarter 2021.PRA Health Sciences Inc is a United State based full-service global contract research organization. It provides a broad range of product development services for pharmaceutical and biotechnology companies around the world.

Latest PRAH news

Currently there for this company. Visit our news hub for other news .